PreDiabetes Pipeline Report, 2023 Updates: In-depth Analysis into the Clinical Trials, Latest Drug Approvals, Emerging Drugs, and Growth Prospects | Abbott Laboratories, Medtronic, Roche Diagnostics, Novo Nordisk, Sanofi, Eli Lilly and Company, Johnson &

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, PreDiabetes pipeline constitutes 15+ key companies continuously working towards developing 15+ PreDiabetes treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"PreDiabetes Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the PreDiabetes Market.

The PreDiabetes Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the PreDiabetes Pipeline Report: https://www.delveinsight.com/sample-request/prediabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel PreDiabetes treatment therapies with a considerable amount of success over the years.
• PreDiabetes companies working in the treatment market are NanoPrecision Medical, Caelus Health, Inversago Pharma Inc., Haisco Pharmaceutical Group Co., Ltd., Valbiotis, and others, are developing therapies for the PreDiabetes treatment
• Emerging PreDiabetes therapies in the different phases of clinical trials are- OKV-119, Anaerostipes rhamnosivorans, Intestinimonas, INV-202, HSK7653, Eubacterium Hallii, Totum-63, and others are expected to have a significant impact on the PreDiabetes market in the coming years.
• In March 2021, A Phase II, Multicenter, Randomised, Double-Blind, Placebo-Controlled, Parallel-group Clinical Trial to Study the Efficacy and Safety of HSK7653 in Chinese Patients With Impaired Glucose Tolerance was started by Haisco Pharmaceutical Group Co., Ltd.
• According to the studies, Results from a review of clinical trials show that persons with prediabetes who consume more vitamin D had a 15% decreased chance of acquiring type 2 diabetes. The Annals of Internal Medicine carried the review. Prediabetes is characterised by blood sugar levels that are higher than average but not high enough to be classified as type 2 diabetes

PreDiabetes Overview
A metabolic condition known as pre-diabetes is thought to be a precursor to the onset of diabetes mellitus. It is characterised by blood glucose levels that are higher than usual but not yet at diabetes levels. Although there is no established cause of diabetes, family history and genetics seem to be significant contributors.

Get a Free Sample PDF Report to know more about PreDiabetes Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/prediabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Emerging PreDiabetes Drugs Under Different Phases of Clinical Development Include:
• OKV-119: NanoPrecision Medical
• Anaerostipes rhamnosivorans: Caelus Health
• Intestinimonas: Caelus Health
• Apabetalone: Resverlogix
• BTI-320: Boston Therapeutics
• INV-202: Inversago Pharma Inc.
• HSK7653: Haisco Pharmaceutical Group Co., Ltd.
• Eubacterium Hallii: Caelus Health
• Totum-63: Valbiotis

Route of Administration
PreDiabetes pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Intravenous
• Subcutaneous

Molecule Type
Products have been categorized under various Molecule types, such as
• Small molecule
• Cell Therapy
• Peptides
• Polymer
• Small molecule
• Gene therapy

PreDiabetes Pipeline Therapeutics Assessment
• PreDiabetes Assessment by Product Type
• PreDiabetes By Stage and Product Type
• PreDiabetes Assessment by Route of Administration
• PreDiabetes By Stage and Route of Administration
• PreDiabetes Assessment by Molecule Type
• PreDiabetes by Stage and Molecule Type

DelveInsight's PreDiabetes Report covers around 15+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further PreDiabetes product details are provided in the report. Download the PreDiabetes pipeline report to learn more about the emerging PreDiabetes therapies at:
https://www.delveinsight.com/sample-request/prediabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key companies in the PreDiabetes Therapeutics Market include:
Key companies developing therapies for PreDiabetes are - Abbott Laboratories, Medtronic, Roche Diagnostics, Novo Nordisk, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline, AstraZeneca, Bayer AG, Dexcom, Verily Life Sciences, Livongo Health (now part of Teladoc Health), and others.

PreDiabetes Pipeline Analysis:
The PreDiabetes pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of PreDiabetes with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for PreDiabetes Treatment.
• PreDiabetes key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• PreDiabetes Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the PreDiabetes market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about PreDiabetes drugs and therapies-
https://www.delveinsight.com/sample-request/prediabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

PreDiabetes Pipeline Market Drivers
• Increase in prevalence of prediabetes, increase in Diagnosis and growing investments in research and development are some of the important factors that are fueling the PreDiabetes Market.

PreDiabetes Pipeline Market Barriers
• However, side effects associated with Drugs, lack of Awareness among Patients and other factors are creating obstacles in the PreDiabetes Market growth.

Scope of PreDiabetes Pipeline Drug Insight
• Coverage: Global
• Key PreDiabetes Companies: NanoPrecision Medical, Caelus Health, Inversago Pharma Inc., Haisco Pharmaceutical Group Co., Ltd., Valbiotis, and others
• Key PreDiabetes Therapies: OKV-119, Anaerostipes rhamnosivorans, Intestinimonas, INV-202, HSK7653, Eubacterium Hallii, Totum-63, and others
• PreDiabetes Therapeutic Assessment: PreDiabetes current marketed and PreDiabetes emerging therapies
• PreDiabetes Market Dynamics: PreDiabetes market drivers and PreDiabetes market barriers

Request for Sample PDF Report for PreDiabetes Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/prediabetes-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1 PreDiabetes Report Introduction
2 PreDiabetes Executive Summary
3 PreDiabetes Overview
4 PreDiabetes- Analytical Perspective In-depth Commercial Assessment
5 PreDiabetes Pipeline Therapeutics
6 PreDiabetes Late Stage Products (Phase II/III)
7 PreDiabetes Mid Stage Products (Phase II)
8 PreDiabetes Early Stage Products (Phase I)
9 PreDiabetes Preclinical Stage Products
10 PreDiabetes Therapeutics Assessment
11 PreDiabetes Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 PreDiabetes Key Companies
14 PreDiabetes Key Products
15 PreDiabetes Unmet Needs
16 PreDiabetes Market Drivers and Barriers
17 PreDiabetes Future Perspectives and Conclusion
18 PreDiabetes Analyst Views
19 Appendix
20 About DelveInsight
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Related Reports:

PreDiabetes Market https://www.delveinsight.com/report-store/prediabetes-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'PreDiabetes-Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Latest Reports:

Monkeypox Market https://www.delveinsight.com/report-store/monkeypox-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Monkeypox Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Monkeypox, historical and forecasted epidemiology as well as the Monkeypox market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Pars Planitis Market
https://www.delveinsight.com/report-store/pars-plantis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Pars Plantis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Pars Plantis, historical and forecasted epidemiology as well as the Pars Plantis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products

Typhoid Market https://www.delveinsight.com/report-store/typhoid-fever-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Typhoid Fever Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Typhoid Fever, historical and forecasted epidemiology as well as the Typhoid Fever market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Zika Virus Market https://www.delveinsight.com/report-store/zika-virus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Opioid Use Disorder Market https://www.delveinsight.com/report-store/opioid-use-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Opioid Use Disorder (OUD) - Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Opioid Use Disorder (OUD), historical and forecasted epidemiology as well as the Opioid Use Disorder (OUD) market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Recent Blog's By DelveInsight:

• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr

Contact Us:

Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
Healthcare Consulting
https://www.delveinsight.com/consulting-services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.